Bibliografia

1. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patient with osteoartgritis of the hip or kneee. J Rheumatol 1988 Dec; 15(12): 1988-40.

2. Salaffi F, Leardini G, Canesi B, Mannoni A, Fioravanti A, Caporali R, Lapadula G, Punzi L. Gonorthrisis and Quality Of life Assessment (GOQOLA). Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index in Italian patients with osteoarthritis of the Knee. Osteoarthritis Cartilage 2003 Aug; 11(8): 551-60.

3. Bellamy N, Kean WF, Buchanan WW, Gerecz-Simon E, Campbell J. ouble blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol 1992 Jan; 19(1): 153-9.